全文获取类型
收费全文 | 946篇 |
免费 | 65篇 |
国内免费 | 13篇 |
专业分类
儿科学 | 48篇 |
妇产科学 | 14篇 |
基础医学 | 108篇 |
口腔科学 | 37篇 |
临床医学 | 84篇 |
内科学 | 175篇 |
皮肤病学 | 10篇 |
神经病学 | 17篇 |
特种医学 | 113篇 |
外科学 | 209篇 |
综合类 | 6篇 |
预防医学 | 31篇 |
眼科学 | 12篇 |
药学 | 47篇 |
肿瘤学 | 113篇 |
出版年
2021年 | 14篇 |
2020年 | 8篇 |
2019年 | 8篇 |
2018年 | 17篇 |
2017年 | 13篇 |
2016年 | 16篇 |
2015年 | 18篇 |
2014年 | 15篇 |
2013年 | 20篇 |
2012年 | 29篇 |
2011年 | 19篇 |
2010年 | 31篇 |
2009年 | 21篇 |
2008年 | 29篇 |
2007年 | 33篇 |
2006年 | 25篇 |
2005年 | 36篇 |
2004年 | 38篇 |
2003年 | 26篇 |
2002年 | 39篇 |
2001年 | 21篇 |
2000年 | 45篇 |
1999年 | 22篇 |
1998年 | 31篇 |
1997年 | 50篇 |
1996年 | 46篇 |
1995年 | 25篇 |
1994年 | 21篇 |
1993年 | 14篇 |
1992年 | 20篇 |
1991年 | 16篇 |
1990年 | 26篇 |
1989年 | 24篇 |
1988年 | 22篇 |
1987年 | 12篇 |
1986年 | 22篇 |
1985年 | 16篇 |
1984年 | 7篇 |
1983年 | 17篇 |
1982年 | 8篇 |
1981年 | 7篇 |
1980年 | 7篇 |
1979年 | 6篇 |
1978年 | 8篇 |
1977年 | 9篇 |
1976年 | 10篇 |
1975年 | 8篇 |
1970年 | 5篇 |
1966年 | 6篇 |
1965年 | 9篇 |
排序方式: 共有1024条查询结果,搜索用时 15 毫秒
41.
42.
43.
Salvatore Andreola MD Riccardo A. Audisio MD Vincenzo Mazzaferro MD Roberto Doci MD Leonard Makowka MD PhD Leandro Gennari MD 《Digestive diseases and sciences》1988,33(12):1632-1636
Summary Primary malignant lymphomas of the liver are extremely rare. Thus far, 28 cases (1–13) of this entity have been described, but after careful clinical and histological staging, no other sites of extrahepatic involvement were demonstrated in 17 of these cases (2, 3, 5–13). We recently had the opportunity to investigate and manage a case of true primary malignant peripheral T-cell lymphoma of the liver in a 22-year-old man. To our knowledge this is the first reported case of a primary T-cell lymphoma of the liver. The patient was successfully treated with a right trisegmentectomy and no tumor recurrence has appeared after five years. 相似文献
44.
Anniek KD Visser Nisha K Ramakrishnan Antoon TM Willemsen Valentina Di Gialleonardo Erik FJ de Vries Ido P Kema Rudi AJO Dierckx Aren van Waarde 《Journal of cerebral blood flow and metabolism》2014,34(1):118-125
The PET tracer [11C]5-hydroxytryptophan ([11C]5-HTP), which is converted to [11C]5-hydroxytryptamine ([11C]5-HT) by aromatic amino acid decarboxylase (AADC), is thought to measure 5-HT synthesis rates. But can we measure these synthesis rates by kinetic modeling of [11C]5-HTP in rat? Male rats were scanned with [11C]5-HTP (60 minutes) after different treatments. Scans included arterial blood sampling and metabolite analysis. 5-HT synthesis rates were calculated by a two-tissue compartment model (2TCM) with irreversible tracer trapping or Patlak analysis. Carbidopa (inhibitor peripheral AADC) dose-dependently increased [11C]5-HTP brain uptake, but did not influence 2TCM parameters. Therefore, 10 mg/kg carbidopa was applied in all subsequent study groups. These groups included treatment with NSD 1015 (general AADC inhibitor) or p-chlorophenylalanine (PCPA, inhibitor of tryptophan hydroxylase, TPH). In addition, the effect of a low-tryptophan (Trp) diet was investigated. NSD 1015 or Trp depletion did not affect any model parameters, but PCPA reduced [11C]5-HTP uptake, and the k3. This was unexpected as NSD 1015 directly inhibits the enzyme converting [11C]5-HTP to [11C]5-HT, suggesting that trapping of radioactivity does not distinguish between parent tracer and its metabolites. As different results have been acquired in monkeys and humans, [11C]5-HTP-PET may be suitable for measuring 5-HT synthesis in primates, but not in rodents. 相似文献
45.
C. Roux C. Gennari J. Farrerons J. P. Devogelaer H. Mulder H. P. Kruse C. Picot L. Titeux J. Y. Reginster M. Dougados 《Arthritis \u0026amp; Rheumatology》1995,38(6):851-858
Objective. To compare the efficacy and safety of tiludronate and etidronate at the same dosage (400 mg/day) for the treatment of active Paget's disease of bone. Methods. We studied 234 patients with radiologic lesions characteristic of Paget's disease of bone and serum alkaline phosphatase (AP) concentrations at least twice the upper limit of normal, in a prospective, randomized, double-blind, multicenter clinical trial lasting 6 months. Patients were randomly allocated into 1 of 3 treatment groups: tiludronate for 3 months followed by placebo for 3 months, tiludronate for 6 months, or etidronate for 6 months. Serum AP levels and urinary hydroxyproline excretion were measured at baseline and after 3 months and 6 months. Patients with a reduction of at least 50% in the serum AP concentration were considered to be responders. Results. After 3 months, the proportion of responders was higher in the tiludronate group (57.4%) than in the etidronate group (13.9%) (P < 0.0001). In the etidronate group, this percentage was lower among patients who had received previous treatment with a bisphosphonate (2.3%) than among those who had not (28.6%) (P < 0.01). Previous bisphosphonate treatment was not associated with response in the tiludronate group. After 6 months, the proportion of responders did not differ between the 2 tiludronate groups (60.3% and 70.1%), but was lower in the etidronate group (25.3%) (P < 0.0001). There was a higher proportion of patients with treatment-resistant disease ( < 25% reduction of serum AP) in the etidronate group (51.9%) than in the tiludronate 3-month group (17.9%) or the tiludronate 6-month group (19.5%) (P < 0.0001). Gastrointestinal disturbances were more common, and occurred earlier, with tiludronate, but they were mostly mild, requiring no treatment. Conclusion. Tiludronate at 400 mg/day for 3 months or 6 months is more effective than the same dosage of etidronate for 6 months in the treatment of Paget's disease. 相似文献
46.
JY Nagata TF Rocha‐Lima BP Gomes CC Ferraz AA Zaia FJ Souza‐Filho A De Jesus‐Soares 《Australian dental journal》2015,60(3):416-420
Immature avulsed teeth are not usually treated with pulp revascularization because of the possibility of complications. However, this therapy has shown success in the treatment of immature teeth with periapical lesions. This report describes the case of an immature replanted tooth that was successfully treated by pulp revascularization. An 8‐year‐old boy suffered avulsion on his maxillary left lateral incisor. The tooth showed incomplete root development and was replanted after 30 minutes. After diagnosis, revascularization therapy was performed by irrigating the root canal and applying a calcium hydroxide paste and 2% chlorhexidine gel for 21 days. In the second session, the intracanal dressing was removed and a blood clot was stimulated up to the cervical third of the root canal. Mineral trioxide aggregate was placed as a cervical barrier at the entrance of the root canal and the crown was restored. During the follow‐up period, periapical repair, apical closure and calcification in the apical 4 mm of the root canal was observed. An avulsed immature tooth replanted after a brief extra‐alveolar period and maintained in a viable storage medium may be treated with revascularization. 相似文献
47.
IA Maartens T Wassenberg FJ Halbertsma HAM Marres P Andriessen 《Acta paediatrica (Oslo, Norway : 1992)》2009,98(11):1852-1854
A case report is presented of a rapidly growing congenital nasopharyngeal teratoma (epignathus) in a preterm infant, leading to severe upper airway obstruction. Prenatal diagnosis by ultrasonography did not reveal the condition because the tumour masses were initially small and there was no polyhydramnios. Epignathus is a rare cause of upper airway obstruction of the newborn that can grow rapidly in the neonatal period and should be treated surgically.
Conclusion: Epignathus is a rare cause of upper airway obstruction of the newborn that can grow rapidly in the neonatal period. 相似文献
Conclusion: Epignathus is a rare cause of upper airway obstruction of the newborn that can grow rapidly in the neonatal period. 相似文献
48.
49.
BD Heckman KA Holroyd G Tietjen FJ O'Donnell L Himawan C Utley R Watakakosol & M Stillman 《Cephalalgia : an international journal of headache》2009,29(6):650-661
This study sought to determine if Whites and African-Americans respond similarly to headache treatment administered in 'real-world' headache specialty treatment clinics. Using a naturalistic, longitudinal design, 284 patients receiving treatment for headache disorders completed 30-day daily diaries that assessed headache frequency and severity at pretreatment and 6-month follow-up and also provided data on their headache disability and quality of life at pretreatment and 1-, 2- and 6-month follow-up. Controlling for socioeconomic status and psychiatric comorbidity, hierarchical linear models found that African-Americans and Whites reported significant reductions in headache frequency and disability and improvements in life quality over the 6-month treatment period. African-Americans, unlike Whites, also reported significant decreases in headache severity. Nevertheless, Africans-Americans had significantly more frequent and disabling headaches and lower quality of life after treatment relative to Whites. Although Whites and African Americans responded favourably to headache treatments, more efficacious treatments are needed given the elevated level of headache frequency that remained in both racial groups following treatment. 相似文献
50.
Francesco Cilurzo Francesca Selmin Paola Minghetti Chiara G M Gennari Francesco Demartin Luisa Montanari 《European journal of pharmaceutics and biopharmaceutics》2008,68(3):579-588
The suitability of a poly(sodium methacrylate, methyl methacrylate) (NaPMM), a novel mucoadhesive material, to prepare fast-dissolving microparticles containing nifedipine (NIF) in the range of 25-75% w/w was verified. Microparticles made of a low-viscosity hydroxypropylmethylcellulose (HPMC), were also prepared to compare the NIF release profile and bioadhesive properties. The release test was carried out in oversaturation conditions. The physical state of microparticles was also investigated. The formulation stability was evaluated over a 3-month period in long-term and accelerated conditions. The presence of amorphous NIF within freshly prepared microparticles was attributed to interactions between the drug and both polymers. NaPMM conferred to microparticles suitable mucoadhesive properties and significantly increased NIF dissolution rate in comparison to HPMC. Nevertheless, NIF apparent solubilities obtained by NaPMM microparticles were lower than those obtained by the HPMC set. After 3-month storage in the case of HPMC microparticles, NIF dissolution rate and supersaturation degree significantly decreased due to drug crystallization. As far as NaPMM microparticles are concerned, neither NIF dissolution rate nor apparent solubility significantly changed. 相似文献